Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Total Non-Current Liabilities data on record, last reported at $615.2 million in Q1 2025.

  • For Q1 2025, Total Non-Current Liabilities changed N/A year-over-year to $615.2 million; the TTM value through Mar 2025 reached $615.2 million, changed N/A, while the annual FY2024 figure was $378.6 million, 40.67% down from the prior year.
  • Total Non-Current Liabilities reached $615.2 million in Q1 2025 per MRVI's latest filing, up from $378.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q3 2021 and bottomed at $378.6 million in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $1.0 billion, with a median of $1.2 billion recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: increased 23.27% in 2021, then plummeted 53.33% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.4 billion in 2021, then fell by 0.43% to $1.4 billion in 2022, then tumbled by 53.33% to $638.1 million in 2023, then tumbled by 40.67% to $378.6 million in 2024, then soared by 62.49% to $615.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $615.2 million in Q1 2025, $378.6 million in Q4 2024, and $611.3 million in Q3 2024.